Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular Thyroid Cancer, Graves' Disease, and Graves' Ophthalmopathy.

Mabel Ryder,Mark A. Wentworth,Alicia Algeciras-Schimnich,John C. Morris,James A. Garrity,Jane Sanders,Stuart Young,Paul W. Sanders,Jadwiga Furmaniak,Bernard Rees-Smith

Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular Thyroid Cancer, Graves' Disease, and Graves' Ophthalmopathy.

2021

Mabel Ryder
Mark A. Wentworth
Alicia Algeciras-Schimnich
John C. Morris
James A. Garrity
Jane Sanders
Stuart Young
Paul W. Sanders
Jadwiga Furmaniak
Bernard Rees-Smith

Background: We report the therapeutic use of K1-70™, a thyrotropin receptor (TSHR) antagonist monoclonal antibody, in a patient with follicular thyroid cancer (FTC), Graves' disease (GD), and Grave...

Keywords:

Antagonist
Thyroid cancer
Cancer research
Graves' disease
Medicine
Monoclonal antibody
Graves' ophthalmopathy
Autoantibody
Thyrotropin receptor
Follicular thyroid cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations